Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1985062 · no price history on file
Price series unavailable — No prices available for PBMWW in [1900-01-01, 2026-07-31]. This symbol may require bring-your-own-key (BYOK) data.
| Days to cover7.6d |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
PBMWW is not in the screener universe.
No return windows available for PBMWW.
No risk analytics available for PBMWW.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Harraden Circle Investments, LLC | 1.1M | $20,929 | — | +0.0% |
| Polar Asset Management Partners Inc. | 733,000 | $13,341 | — | +0.0% |
| MMCAP International Inc. SPC | 600,000 | $10,920 | — | +0.0% |
| TORONTO DOMINION BANK | 503,312 | $9,060 | — | +0.0% |
| Calamos Advisors LLC | 500,000 | $9,050 | — | +0.0% |
| Saba Capital Management, L.P. | 297,847 | $5,406 | — | +0.0% |
| Clear Street Group Inc. | 257,209 | $4,681 | — | +0.0% |
| ARISTEIA CAPITAL, L.L.C. | 215,319 | $3,908 | — | −13.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.
No reported quarters on file for PBMWW.
